Zobrazeno 1 - 10
of 32
pro vyhledávání: '"B. V. Egorova"'
Autor:
A. A. Artyukhov, V. A. Golovachenko, S. M. Deev, B. V. Egorova, K. V. Kokov, T. M. Kuznetsova, A. V. Kurochkin, E. N. Lebedenko, K. A. Makoveeva, A. A. Pankratov, A. D. Plyutinskaya, M. A. Proshin, D. Yu. Chuvilin, A. A. Shulga, A. D. Kaprin
Publikováno v:
Nanobiotechnology Reports. 17:429-435
Autor:
L. S. Zamurueva, B. V. Egorova, I. S. Ikonnikova, A. D. Zubenko, A. V. Pashanova, V. A. Karnoukhova, A. A. Mitrofanov, A. L. Trigub, A. A. Moiseeva, A. B. Priselkova, O. A. Fedorova, S. N. Kalmykov
Publikováno v:
Dalton Transactions.
In this work, we synthesized two new benzo-18-azacrown-6 ethers bearing picolinate and pyridine pendant arms and studied the copper complexes of these ligands, as well as those of an acetate analog.
Publikováno v:
Moscow University Chemistry Bulletin. 77:1-37
Autor:
G. M. Proshkina, S. M. Deev, P V Shegai, Konstantin Kokov, A D Kaprin, B V Egorova, Anna D. Plyutinskaya, A. A. Pankratov, V. A. Golovachenko, M S Vorontsova, E N Lebedenko, E. R. Nemtsova, D. Yu. Chuvilin, A. A. Shulga
Publikováno v:
Bulletin of Experimental Biology and Medicine. 171:627-632
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides 177Lu (ZHER2-HSA-chelator-177Lu) or 212Pb (ZHER2-HSA-chelator-212Pb). The objective was to e
Autor:
Stepan N. Kalmykov, Valentina A. Karnoukhova, Olga A. Fedorova, Anastasia A. Smirnova, Alexander L. Trigub, Ekaterina V. Matazova, Artem Mitrofanov, Ekaterina A. Konopkina, Anna V. Pashanova, Gleb Yu. Aleshin, B. V. Egorova, Anastasia D. Zubenko
Publikováno v:
European Journal of Inorganic Chemistry. 2021:3344-3354
Autor:
Stepan N. Kalmykov, Zeena S. Pillai, B. V. Egorova, Olga A. Fedorova, Lyubov S. Zamurueva, Anna V. Pashanova, Anastasia D. Zubenko
Publikováno v:
Macroheterocycles. 14:157-163
Autor:
A. Larkin, V. Panchenko, K. A. Makoveeva, K. Kokov, M. A. Proshin, D. Chuvilin, A. Moiseeva, Igor V. Reshetov, B. V. Egorova, A. V. Lyundup, A. G. Demchenko
Publikováno v:
Journal of Surface Investigation: X-ray, Synchrotron and Neutron Techniques. 14:S99-S104
A method for obtaining radiopharmaceutical nanoconstruction [212Pb]DOTATATE for investigations in the field of neuroendocrine tumors therapy has been developed. A laboratory generator of β-emitting radionuclide 212Pb with an operating efficiency of
Autor:
Olga A. Fedorova, Lyubov S. Zamurueva, B. V. Egorova, Stepan N. Kalmykov, Anastasia D. Zubenko
Publikováno v:
Mendeleev Communications. 31:194-196
Two methods for obtaining of benzoaza-15(18)-crown-5(6) ethers from 1,2-bis(2-iodoethoxy)benzene or diethyl 1,2-phenylenebis(oxy)diacetate have been reported. The ability of the crown ethers to coordinate lead(II) ions has been estimated by potentiom
Autor:
G.A. Posypanova, Nikolay A Titchenko, Vasiliy N Osipov, Anton V Kolotaev, D. S. Khachatryan, B. V. Egorova, Anzhelika O Fedotova, Stepan N. Kalmykov
Publikováno v:
Journal of peptide science : an official publication of the European Peptide SocietyREFERENCES. 27(12)
Somatostatin analogues play an important role in the therapy of neuroendocrine tumors by binding to somatostatin receptors on the surface of cancer cells. In this work, we analyze the receptor-binding affinity and in vitro stability of a novel ultra-
Publikováno v:
Russian Chemical Reviews. 88:901-924
This review considers the already used and potential α- and β-emitting cationic radionuclides for targeted radionuclide therapy. Recent results of laboratory, preclinical and clinical applications of these radionuclides are discussed. As opposed to